Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

The Use of Erythropoietic-Stimulating Agents (ESAs) with Ruxolitinib in Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), and Post-Essential Thrombocythemia Myelofibrosis (PET-MF).

Mary Frances McMullin, MD, Claire N Harrison, DM FRCP FRCPath, Dietger Niederwieser, Hilde Demuynck, Nadja Jakel, Andres Sirulnik, MD, PhD, Mari McQuity, RN, MPH, Viktoriya Stalbovskaya, PhD, Christian Recher, MD, Koen Theunissen, MD, Heinz Gisslinger, MD, Jean-Jacques Kiladjian, MD, PhD, Haifa-Kathrin Al- Ali

Blood (2012) 120 (21): 2838.

https://doi.org/10.1182/blood.V120.21.2838.2838

Published: 2012

Journal Articles

PAD Is a Highly Effective Regimen for the Treatment of Patients with Relapsed Refractory Multiple Myeloma.

Michel Delforge, MD, PhD, Ann Janssens, MD, Daan Dierickx, MD, Johan Maertens, MD, Koen Theunissen, MD, Peter Vandenberghe, MD,PhD, Gregor Verhoef, MD,PhD

Blood (2006) 108 (11): 5095.

https://doi.org/10.1182/blood.V108.11.5095.5095

Published: 2006

Journal Articles

Natural History of Post-Allogeneic HSCT EBV-Reactivation: A Single Center Retrospective Survey.

Helene M. Schoemans, MD, Koen Theunissen, MD, Marc Boogaerts, MD, PhD, Johan Maertens, MD

Blood (2005) 106 (11): 3232.

https://doi.org/10.1182/blood.V106.11.3232.3232

Published: 2005

Journal Articles

Role of Plasmin and uPAR in Bone Marrow HSC/HPC Retention and Mobilization.

Marc Tjwa, MD, PhD, Lieve Moons, PhD, Koen Theunissen, MD, Rute Moura, MSc, PhD, Francesco Blasi, MD, PhD, Mieke Dewerchin, PhD, Nicolai Sidenius, PhD, Desire Collen, MD, PhD, Peter Carmeliet, MD, PhD

Blood (2005) 106 (11): 472.

https://doi.org/10.1182/blood.V106.11.472.472

Published: 2005

Journal Articles

Fludarabine Phosphate-Based Nonmyeloablative Stem Cell Transplantation in the Elderly Patients: A BHS Study.

Dominique Bron, MD, PhD, Pierre Zachée, MD, Johan Maertens, MD, Koen Theunissen, MD, Augustin Ferrant, MD, PhD, Philippe Martiat, MD, PhD, Chantal Doyen, MD, Luc Noens, MD, Wilfried Schroyens, MD, Dominique Sellesslag, MD, Hilde Demuynck, MD, Rick Schots, MD, PhD, Anne De Meuter, Marc Boogaerts, MD, PhD

Blood (2004) 104 (11): 5046.

https://doi.org/10.1182/blood.V104.11.5046.5046

Published: 2004

Journal Articles

Novel Role of Plasmin in Mobilization and of uPAR in Retention of Hematopoietic Stem/Progenitor Cells in the Bone Marrow Niche: Therapeutic Implications.

Marc Tjwa, MD, Nicolai Sidenius, PhD, Koen Theunissen, MD, Rute Moura, MSc, Lieve Moons, PhD, Stefan Janssens, MD, PhD, Francesco Blasi, MD, Desire Collen, MD, PhD, Peter Carmeliet, MD, PhD

Blood (2004) 104 (11): 117.

https://doi.org/10.1182/blood.V104.11.117.117

Published: 2004

Journal Articles

Targeted Pre-Emptive Anti- Aspergillus Therapy in Neutropenic Patients Not Receiving Empirical Antifungal Therapy.

Johan A. Maertens, MD, Koen Theunissen, MD, Gregor Verhoef, MD, Johnny Verschaekelen, MD, PhD, Katrien Lagrou, MD, PhD, Eric Verbeken, MD, PhD, Jan Verhaegen, MD, PhD, Wouter Meersseman, MD, Alexander Wilmer, MD, PhD, Marc Boogaerts, MD, PhD, Johan Van Eldere, MD, PhD

Blood (2004) 104 (11): 2231.

https://doi.org/10.1182/blood.V104.11.2231.2231

Published: 2004

Journal Articles

Can Addition of GM-CSF in Adult Haplo-Identical Transplant Who Cannot Benefit from NK Alloreactivity Improve the Relapse Rate of Advanced Leukemia: A 3 Step Study.

Philippe Lewalle, MD, Alain Delforge, PhD, Berengere Nowak, BS, Virginie Misplon, Laurence Lagneaux, PhD, Koen Theunissen, MD, PhD, Jalil Bennani, MD, Dominique Bron, MD, PhD, Philippe Martiat, MD, PhD

Blood (2004) 104 (11): 4975.

https://doi.org/10.1182/blood.V104.11.4975.4975

Published: 2004

NARROW

The Use of Erythropoietic-Stimulating Agents (ESAs) with Ruxolitinib in Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), and Post-Essential Thrombocythemia Myelofibrosis (PET-MF).

PAD Is a Highly Effective Regimen for the Treatment of Patients with Relapsed Refractory Multiple Myeloma.

Natural History of Post-Allogeneic HSCT EBV-Reactivation: A Single Center Retrospective Survey.

Role of Plasmin and uPAR in Bone Marrow HSC/HPC Retention and Mobilization.

Fludarabine Phosphate-Based Nonmyeloablative Stem Cell Transplantation in the Elderly Patients: A BHS Study.

Novel Role of Plasmin in Mobilization and of uPAR in Retention of Hematopoietic Stem/Progenitor Cells in the Bone Marrow Niche: Therapeutic Implications.

Targeted Pre-Emptive Anti- Aspergillus Therapy in Neutropenic Patients Not Receiving Empirical Antifungal Therapy.

Can Addition of GM-CSF in Adult Haplo-Identical Transplant Who Cannot Benefit from NK Alloreactivity Improve the Relapse Rate of Advanced Leukemia: A 3 Step Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only